化學(xué)結(jié)構(gòu)和藥物代謝ChemicalStructureandMetabolism課件_第1頁(yè)
化學(xué)結(jié)構(gòu)和藥物代謝ChemicalStructureandMetabolism課件_第2頁(yè)
化學(xué)結(jié)構(gòu)和藥物代謝ChemicalStructureandMetabolism課件_第3頁(yè)
化學(xué)結(jié)構(gòu)和藥物代謝ChemicalStructureandMetabolism課件_第4頁(yè)
化學(xué)結(jié)構(gòu)和藥物代謝ChemicalStructureandMetabolism課件_第5頁(yè)
已閱讀5頁(yè),還剩178頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

Chapter3

Chemical

StructureandMetabolism第三章

化學(xué)結(jié)構(gòu)與藥物代謝

Section1IntroductionThephysicochemicalpropertiesofdrugsthatpredispose(使偏向于)themtogoodabsorption,suchaslipophilicity(親脂性),areimpediment(妨礙)totheirelimination.Asaconsequence,theeliminationofdrugsnormallyrequirestheirconversionintowatersolublecompoundsbyaprocessofmetabolism,whichenablesexcretionviaurineorfaeces(排泄物).

MetabolismMetabolismisoftenthemajorfactordefiningthepharmacokineticsofdrugs,whichinturncaninfluencetheefficacyandside-effectprothesecompounds.Thechemicalnatureandmeansofidentificationofthesebiotransformationshavebeenwellknownformanyyears,butinrecentyearsmajoradvanceshavebeenmadeintheunderstandingoftheenzymesresponsibleforthemetabolicpathways.PhaseIBiotransformationPhaseIreactionsintroduce,orotherwiseproduce,afunctionalgroup(e.g.–OH,-SH,-NH2,-COOH)intothemolecule.Thesereactionincludehydrolysis(水解),reduction(還原)andoxidation(氧化)andareperformedbyawiderangeofenzymes.OftenthesePhaseIreactionsprecedePhaseIIbiotransformations.第I相生物轉(zhuǎn)化主要是官能團(tuán)反應(yīng),包括對(duì)藥物分子的氧化、還原和羥化等,在藥物分子中引入或暴露極性基團(tuán),如羥基、羧基、巰基和氨基。PhaseIIBiotransformationPhaseIIreactionsinvolvetheconjugation(軛合)onasuitablechemicalgroupofthemolecule(parentcompoundormetabolite)andmanydrugscontainsuitablefunctionalgroupswithoutrecourse(依賴)toPhaseImetabolism.PhaseIIreactionsincludeconjugationwithglucuronic(葡萄糖醛酸)acid,sulfate,glutathione(谷光苷肽)oraminoacids(e.g.glycine(甘氨酸),taurine(?;撬?,glutamine(谷氨酰胺),allofwhichincreasethewatersolubilityofthemolecule.Conjugationreactions,suchasN-acetylationofaminesandN-,O-andS-methylation,generallyresultinmorelipophilicproducts.1.CytochromeP-450enzymesystem(CYP-450)(細(xì)胞色素P-450酶系)CytochromeP-450enzymesystem(CYP-450)areagroupofnonspecificenzymes(Heme-coupledmonooxygenases)inlivermicrosomes.Inaanotherword,CYP450isaliverhomogenate(勻漿)fractionderivedfromsmoothendoplasmicreticulum(光滑內(nèi)質(zhì)網(wǎng)).CYP-450是一組鐵原卟啉偶聯(lián)單加氧酶,位于肝微粒體中,是主要的藥物代謝酶系。CYP-450屬于體內(nèi)的氧化-還原酶,主要進(jìn)行氧化反應(yīng),需要NADPH和氧分子共同參與。也能進(jìn)行還原反應(yīng),將含偶氮和硝基還原成芳香伯胺。

2.Reductionenzymesystem(還原酶系)CYP-450酶系(CYP-450)醛-酮還原酶(ketoreductase):屬于氧化-還原酶。需要NADPH或NADP作為輔酶。谷胱甘肽氧化還原酶(glutathioneoxido-reductase)醌還原酶FlavinMonooxygenase(FMO)

(黃素單加氧酶)TheFMOaremicrosomalenzymesandmanyofthereactionstheycatalysecanalsobecatalysedbycytochromeP450.ThecommonestFMOreactionistheoxidationofnucleophilictertiaryaminestoN-oxides,althoughprimaryandsecondaryaminesandseveralsulfur-containingdrugsarealsosubstrates.FMO通常對(duì)N和S雜原子進(jìn)行氧化,而不發(fā)生雜原子的脫烷基化反應(yīng)。Monoamineoxidase(MAO)(單胺氧化酶)MAOisinvolvedintheoxidativedeaminationofamines.Substratesincludeanumberofendogenous(內(nèi)源的)amines.HydrolysisEsterase(酯酶)Ingeneral,estersandamidesarehydrolyzedbyenzymesintheblood,livermicrosomes,kidneys,andothertissues.Estersarerapidlyhydrolyzedbyesterases.水解酶位于血漿、肝、腎和腸中,參與酯和酰胺的水解。但酰胺較穩(wěn)定而難水解。EsterasesAcetylcholinesterase(乙酰膽堿酯酶)cholinesterase(pseudocholinesterase擬膽堿酯酶)Arylesterase(芳基酯酶)Livermicrosomalesterases(肝微粒體酯酶)Otherunclassifiedliveresterases環(huán)氧化物酶等。Table1ThedrugmetabolizingEnzymesEnzymePhaseReactionLocalicationAlcohol(醇)dehydrogenaseIOxidationCytosol(胞質(zhì)溶膠)Aldehyde(醛)dehydrogenaseIOxidationMitochondria,CytosolAldehydeoxidaseIOxidationCytosolCarbonyl(羰基)reductaseIReductionandOxidationCytosolCarboxylesterase(酯酶)IHydrolysisMicrosomes,CytosolCytochromeP450IOxidationorReductionMicrosomesDiamineoxidase(氧化酶)IOxidationMitochondria(線粒體)Epoxide(環(huán)氧化物)hydrolaseIHydrolysisMicrosomes,CytosolFlavin(黃素)MonooxygenaseIOxidationMicrosomesSection3PhaseIBiotransformation1.Oxidations2.Reductions3.Dehalogenation4.Hydrolysis1.OxidationsI.OxidationofcompoundscontainingCII.OxidationofcompoundscontainingNIII.O-dealkylationofethers

IV.OxidationofcompoundscontainingSV.OxidationofalcoholandaldehydesI.OxidationofcompoundscontainingCA.AromatichydroxylationB.OlefinicoxidationC.AliphaticandalicyclichydroxylationsCharacteristicsofaromatichydroxylation(1)

1.Formonosubstitutedbenzenecompounds,parahydroxylationusuallypredominates,withsomeorthoproductbeingformed.2.Incaseswherethereismorethanonephenylring,onlyoneringisusuallyhydroxylated.Phenytoin

(苯妥英)Phenylbutazone

(保泰松)HighpotencyLesstoxicityClonidine

(可樂(lè)定)Probenecid

(丙磺舒)Polycyclicaromatichydrocarbons

(carcinogenesis)AttentionHowever,itshouldbepointedoutthatwhereothercompetitivepathwaysofbiotransformationexist,theimportanceofareneoxideformationcanbediminished.Morevulnerablesubstituentswillbemetabolizedpreferentially,thusfacilitatingexcretion.B.Olefinic(烯烴)Oxidation

Olefinicoxidationisanalogoustoaromaticoxidation,involvinganepoxideintermediate.Stableepoxidesandvicinaldihydrodiolshavebeenisolated.

Carbamazepine

(卡馬西平)AflatoxinB1

(黃曲霉素)C.Aliphafic(脂肪族)andAlicyclic(脂環(huán)族)Hydroxylations

priorityAliphaficandAlicyclicHydroxylationsAlkylsidechainsCarbonsadjacenttoSP2carbon

Alicyclic

(脂環(huán)族)SodiumValproate

(丙戊酸鈉)AlkylsidechainsAmobarbitar

(異戊巴比妥)Ibuprofen

(布洛芬)

OxidationofCadjacenttoSP2carbonThemethylenegroupsadjacenttoSP2carbongenerallyareactivatedposition,e.g.,αtoacarbonyl;αtoadoublebond(allyl,烯丙基);αtoaphenylring(benzyl).TheyareoxidizedtothehydroxymethylderivativebyCYP-450.Diazepam(地西泮)Temazepam替馬西泮αtoacarbonylTolbutamide

(甲苯磺丁脲)benzylToluenebenzylPentazocin(鎮(zhèn)痛新)allylTetralin(1,2,3,4-tetranaphthalene)AlicyclicbenzylAcetohexamide

(醋磺己脲)AlicyclicII.OxidationofcompoundscontainingN

A.N-DealkylationB.N-OxidationA.N-DealkylationThemechanismfortheN-dealkylationreactionisoxidationoftheα-carbon,generatinganunstablecarbinolamine(甲醇胺)thatcollapsestoyieldtheN-dealkylatedsubstrateandthecarbonylderivativeofthesubstituent.ClassificationofN-DealkylationPropranol(普萘洛爾)Amphetamine(苯丙胺)CharacteristicsofN-Dealkylation1.SomeoftheNsubstituentsremovedbyoxidativedealkylationaremethyl,ethyl,n-propyl,isopropyl,n-butyl,allyl,benzyl,andothershavinganα-H.2.Substituentsthataremoreresistanttodealkylationincludethetert-butyl(noα-H)andthecyclopropylmethyl.3.Ingeneral,tertiaryaminesaredealkylatedtosecondaryaminesfasterthansecondaryaminesaredealkylatedtoprimaryamines.Katamine(氯胺酮)Lidocaine(利多卡因)toxicityImipramine(丙咪嗪)Desipramine地昔帕明ImipramineN-IsopropylmethoxamineB.N-OxidationTertiaryaminesareoxidizedtotheN-oxides;whereassecondaryandsomeprimaryaminesareconvertedintohydroxylamines(羥胺).Theformationofhydroxylaminesmayaccountforthetoxicityofmanyaromaticamines.FMO、CYP-450andMAON-Oxidation

noα-hydrogenReversible可逆TertiaryaminesGuanethidine(呱乙啶)stableTertiaryaminesDapsone(氨苯砜)抗麻風(fēng)藥noα-hydrogenThemechanismwhichsomearomaticprimeandsecondaryaminesoxidetoeffecttoxicity

Acetaminofluorene

(2-乙酰氨基芴)

III.O-DealkylationofethersOxidativeO-dealkylationofethersisacommonmetabolicreaction.Themajorityofethergroupsindrugmoleculesarearomaticethers.Theseethersareoxidizedbylivermicrosomaloxidases.ThemechanismofO-dealkylationThemechanismofdealkylationisanalogoustothatofN-dealkylation,oxidationoftheα-carbon,andsubsequentdecompositionoftherelativelyunstablegemdiol.Thesubstituentalkylgroupleavesasacarbonylderivative.gemdiolCodeine(可待因)Phenacetin(非那西汀)Indomethacin

(吲哚美辛)InfluencingfactorstotherateofO-dealkylation1.TherateofO-dealkylationisafunctionofchainlength,i.e.,increasingchainlengthreducestherateofdealkylation.2.Stericfactorsandringsubstituentsinfluencetherateofdealkylation,butarecomplicatedbyelectroniceffects.3.Somedrugmoleculescontainmorethanoneethergroup,inwhichcase,usuallyonlyoneetherisdealkylated.Methoxamine(甲氧明)IV.OxidationofcompoundscontainingsulfurA.S-DealkylationB.OxidativeS-DesulfurationC.S-Oxidation6-Methylmercaptopurine

(6-甲硫嘌呤)A.S-DealkylationactiveanticancerdrugCYP-450B.OxidativeS-DesulfurationC=OP=OP=SC=SThiopental(硫噴妥)S-DesulfurationMono-oxygenase殺蟲(chóng)藥對(duì)硫磷S-DesulfurationMonooxygenaseC.S-OxidationThioridazine(硫利達(dá)嗪)S-OxidationHigheractivity免疫抑制劑

OxisuranV.OxidationofAlcohols

AlcoholdehydrogenaseisanNAD-specificenzymelocatedinthesolublefractionoftissuehomogenates(組織勻漿).Itexhibitsabroadspecificityforalcohols.MetabolismsofAlcoholsMostprimaryalcoholsaldehydesothersecondarytertiaryalcoholsSomesecondaryalcoholsconjugationketonesexcretionacidOxidationofethanolethanoldehydrogenaseamicrosomalenzymesystem(M.E.O.S.)2/3InintoxicationEthylaldehyde1/3OxidationofMethanol

Methanol

dehydrogenaseformaldehyde1/6therateofethanolcatalase(過(guò)氧化氫酶)

xanthine(黃嘌呤)oxidaseEthanoldepressestherateofmethanoloxidationbyactingasacompetitivesubstrateforalcoholdehydrogenase,reducingtheformationofthetoxicmetabolite.

Mefenamic(甲滅酸)XanthineoxidasealdehydeoxidasedehydrogenaseOxidationofAldehydesEndogenousaldehydesPrimaryalcoholsbiogenicaminesexogenousaldehydescarboxylicacids2.ReductionsI.CarbonylreductionII.NO2reductionIII.AzoreductionI.ReductionofketoneKetonesarestabletofurtheroxidationandconsequentlyyieldreductionproductsasmajormetabolites.alcoholsketonesdehydrogenaseAcetohexamide(醋磺己脲)S-(-)A.StereospecificS-(+)-Methadone(美沙酮)S-(-)StereospecificNaltrexone(納曲酮)

StereospecificWarfarin(華法林)R-WarfarinquickB.Stereo-selectiveII.NitroReductionNitrocompoundsarereducedtoaromaticprimaryaminesbyanitro-reductase,presumablythroughnitrosoamineandhydroxylamineintermediates.Thesereductasesarenotsolelyresponsibleforthereductionofazoandnitrocompounds,probablybecauseofreductionbythebacterialflora(細(xì)菌群落)intheanaerobic(厭氧)environmentoftheintestine.

Themechanismofnitroreduction4-Nitroquinoline-1-oxide

(4-硝基喹啉-1-氧化物)Nitrobenzene

(硝基苯)Clonazapam(氯硝西泮)III.AzoReductionAnumberofazocompoundsareconvertedtoaromaticprimaryaminesbyCYP-450,NADPH-CYP-450enzymesysteminthelivermicrosomesandbacterialreductaseintheintestine.ThemechanismofazoreductionSulfasalazine

(柳氮磺胺吡啶)3.DehalogenationOxidativedehydrohalogenation(脫鹵化氫作用)Reductivedehalogenation(還原脫鹵)Hydrolyticdehalogenation(水解脫鹵)OxidativedehydrohalogenationRCH2XRCHOR1R2CHXR1CORRCHX2RCOXCHX3XCOX

RCOCHX2RCOCOXα-HandXCYP-450Chloramphenicol(氯霉素)OxidativedehydrohalogenationCarbontetrachloride

CCl4induceslivernecrosis(壞死),whichismediatedthroughanactivemetabolite.

ReductivedehalogenationHalothane氟烷(1)OxidativedehydrohalogenationHalothane氟烷(2)4.HydrolysisIngeneral,estersandamidesarehydrolyzedbyenzymesintheblood,livermicrosomes,kidneys,andothertissues.Estersarerapidlyhydrolyzedbyesterases(酯酶).Thereactionofhydrolysis

ROCOR1ROH+R1COOH

RONO2ROH+HNO3

ROSO3HROH+H2SO4

RNHCOR1RNH2+R1COOHSuccinylcholine

(氯化琥珀膽堿)Aspirin(阿司匹林)Diphenoxylate

(地芬諾酯)止瀉作用比原藥強(qiáng)5倍diphenoxylicacid地芬諾酸Atropine(阿托品)Estersthatarestericallyhinderedaremoreslowlyhydrolyzedandmayappearunchangedintheurine.50%unchanged

50%unhydrolyzedbiotransformedproductsAmidesaremorestabletohydrolysisthanestersProcainamide(普魯卡因胺)Procaine(普魯卡因)Phthalylsulfathiazole

succinylsulfathiazolePhaseImayproduceoneormoreofthefollowingchangesDecreasedpharmacologicactivity--deactivationIncreasedpharmacologicactivity--activationIncreasedtoxicity--intoxicationAlteredpharmacologicactivitySection4PhaseIIBiotransformationTheconjugatesaremorepolarandlesslipid-solublethantheoriginaldrugand,therefore,willresultinmorerapideliminationofthedrugfromtissues.Theconjugationmechanismsarelargelyresponsibleforthedeactivationandenhancedexcretionofmanydrugs,whichwouldotherwiseremaininthebodyandexertprolongedpharmacologicactivity.

ClassificationofPhaseII1.Glucuronicacidconjugation2.Sulfateconjugation3.Conjugationwithaminoacids4.Glutathioneconjugation5.Acetylation6.MethylationP-aminosalicylicAcetylationO-SulfateconjugationN-GlucuronicacidconjugationO-GlucuronicacidconjugationGlucuronicacidconjugationConjugationwithglycineActivatedintermediatesinPhaseIIreactionAsarule,theconjugatingintermediatedoesnotreactdirectlywiththedrug,buteitherinanactivatedformorwithanactivatedformofthedrug.Mostoftentheseactivatedintermediatesarenucleotides(核苷酸),andthereactioniscatalyzedbyspecifictransferases(轉(zhuǎn)移酶).1.GlucuronicAcidConjugationGlucuronide(葡萄糖醛酸)formationisoneofthemostcommonroutesofdrugmetabolismandaccountsforamajorshareofthemetabolites.Itssignificanceliesinthereadilyavailablesupplyofglucuronicacidinliverandinthelargenumberoffunctionalgroupsformingglucuronideconjugates.Invariably,theglucuronideconjugatesarepharmacologicallyinactive.Thereactioninvolvesthecondensationofthedrugoritsbiotransformationproductwiththeactivatedformofglucuronicacid,uridinediphosphateglucuronicacid(尿苷-5-二磷酸-α-D-葡糖醛酸,UDPGA).UridineDiphosphateGlucuronicAcid(UDPGA)GlucuronicAcidConjugationX=-O-、-N-、-S-、-OCO-。HXRglucuronyltransferase(UDP-葡醛酸轉(zhuǎn)移酶)βwatersolubilityTheactionofglucuronidationWiththeattachmentofthehydrophiliccarbohydratemoietycontaininganionizablecarboxylgroup,alipid-solubledrugcanbeconvertedintoamorewater-solublesubstancethatispoorlyreabsorbedbytherenaltubulesandmorereadilyexcretedinbileorurine,whereitislikelytoberecognizedbythebiliaryorrenalorganicacidtransportsystems.EnterohepaticrecyclingNotallglucuronidesareexcretedbythekidneys,however;someareexcretedintothebile,andthenintotheintestines.Theenzymeβ-glucuronidase(葡糖醛酸酶),whichispresentintheintestines,maythenhydrolyzetheconjugate,releasingthedrugtobereabsorbedandenterintotheenterohepaticshunt.Thisprocessisknownasenterohepaticrecycling.Acetaminophen

(撲熱息痛)Chloramphenicol(氯霉素)Ibuprofen

(布洛芬)Desipramine

(地昔帕明)脂肪胺中堿性較強(qiáng)的伯胺、仲胺結(jié)合能力強(qiáng),易進(jìn)行軛合反應(yīng)p-Aminosalicylicacid

對(duì)氨基水楊酸芳胺的反應(yīng)性小,進(jìn)行葡萄糖醛酸軛合反應(yīng)也比較少M(fèi)eprobamate

(甲丙氨酯)磺胺噻唑(Sulfathiazole)硫醇硫代羧酸Phenylbutazone

(保泰松)Sulfinpyrazone

(硫吡宗)Morphine(嗎啡)WeakopioidantagonistStrongopioidagonist2.SulfateConjugationTheformationofsulfateconjugatesisacommonbiochemicalreactionforbothendogenouscompoundsandfordrugsandotherforeigncompounds.SulfatereactionAdrugissulfatedbytransferofanactivesulfatefrom3‘-phosphoadenosine-5’-phosphosulfate(3’-磷酸腺苷-5’-磷酰硫酸,PAPS)tothedrugacceptor,thatinvolvessulfokinases(硫激酶)(orsulfotransferases).3‘-Phosphoadenosine-5’-Phospho-Sulfate(PAPS)SulfateConjugationROHR—O—SO3HR+(toxicity)ArOHAr—O—SO3HRNH2R—NHSO3HArNH2Ar—NHSO3HRR’NOHRR’NOSO3HRR’N+

(toxicity)Salbutamol

(沙丁胺醇)TheCharacteristicsofSulfateConjugationGenerally,sulfationisahighaffinity,lowcapacityprocessincontrasttoglucuronidationwhichislowaffinity,highcapacity.Thetotalpoolofsulfateisusuallylimitedandcanbereadilyexhausted.Withincreasingdosesofadrug,therefore,conjugationwithsulfatebecomesalesspredominantpathway.Acetaminophen

(撲熱息痛)Athigherdosestherelativeamountof

glucuronideincreases.Sulfateconjugationofsomehydroxylamine(羥胺)formshepatotoxicity(肝臟毒性)andcarcinogenicity(致癌性)3.ConjugationwithAminoAcidsGlycineisthemostcommonaminoacidthatformsconjugateswitharomatic,aryl-aliphatic(芳烷基),andheterocycliccarboxylicacids.Theactiveformofaceticacid(CoASH)Brompheniramine(溴苯那敏)Benzoicacid(苯甲酸)在氨基酸軛合反應(yīng)中,主要是取代的苯甲酸參加反應(yīng)Salicylicacid(水楊酸)4.GlutathioneConjugationGlutathione(GSH)conjugatestoelectrophilicmoietiesofdrugsortheirmetabolites.glycinecysteineglutamicacidGlutathioneS-transferasesappeartohavetwomainrolesOneistheconjugationofpotentiallyharmfulelectrophileswiththeendogenousnucleophile,GSH,therebyprotectingothernucleophiliccentersinthecell,suchasthosethatoccurinproteinsandnucleicacids.Thesecondisameansofexcretionfortheseelectrophiles,becauseonceconjugatedwithGSH,theyareusuallyexcretedinthebileandintheurine.Nucleophilicsubstitutionreaction(SN2)

R-X-YR-X-SG

X=CH2,O,SY=halides,=sulfonate(磺酸酯)=epoxides,GlutathioneS-transferases在體內(nèi)清除由于代謝產(chǎn)生的有害的親電性物質(zhì)GSH在體內(nèi)清除由于代謝產(chǎn)生的有害的親電性物質(zhì)RXR-SGROHR—O—SO3HRSGRR’NOHRR’NOSO3HRR’NSGRCOClRCO-SGCHCl3ClCOClGSCOSGThepathwayofmercapturicacidsynthesis

mercapturicacids(硫醇尿酸)

excretedMorphine(嗎啡)GSHS-alkenetransferasecatalyzestheconju-gationofGSHwithα,β-unsaturatedcarbonylcompounds,analogoustonucleophilicattackontheβ-carbonofanactivateddoublebond.Michael加成反應(yīng)5.Acetylation

Conjugationreactions,suchasN-acetylationofaminesgenerallyresultinmorelipophilicproducts.AcetylCoARX=RNH2,ArNH2,aminoacid,RSO2NH2,RNHNH2,RCONHNH2Aminosalicylate

(對(duì)氨基水楊酸)對(duì)堿性較強(qiáng)的脂肪族伯胺和仲胺,乙?;磻?yīng)通常較少,即使進(jìn)行結(jié)合率也較低。但對(duì)于大多數(shù)芳香伯胺,由于其堿性中等極易進(jìn)行乙酰化反應(yīng)。Isoniazid

(異煙肼)Conjugationreaction6.MethylationMethylationisacommonbiochemicalreactionbutappearstobeofgreatersignificanceinthemetabolismofendogenouscompoundsthanfordrugsandotherforeigncompounds.Methylationdiffersfromotherconjugationprocessesinthattheproductsformedmayinsomecaseshaveasgreatorgreaterpharmacologicactivitythantheparentmolecule.TheprocessofmethylationMethylationA.O-methylationB.N-methylationC.S-methylationA.O-methylation

TheprocessofO-methylationiscatalyzedbythema

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論